Reaction of R-Selenoorganolithium Compounds
m/z 320 (M+, 40), 163 (80), 135 (100). Anal. Calcd for C16H20-
SiSe: C, 60.17; H, 6.31. Found: C, 60.32; H, 6.38. HPLC
(Daicel Chiralpak AD-H, hexane, 0.5 mL/min) tR 8.1 (S) and
8.9 (R) min (66% ee).
1H NMR δ 0.87 (d, 3H, J ) 6.4 Hz), 1.00-1.75 (m, 8H), 2.13
(s, 1H), 2.23-2.30 (m, 1H), 4.45 (s, 1H), 7.13-7.40 (m, 10H);
13C NMR δ 20.8, 30.7, 31.1, 34.9, 37.2, 59.2, 74.5, 126.7, 127.3,
127.8, 128.6, 129.2, 130.1, 134.7, 140.4; IR (neat) 3446, 3059,
2925, 2855, 1455, 1375; 1156, 1045, 989, 737, 700 cm-1; MS
(FAB) m/z 385 (M+ - OH). Anal. Calcd for C20H24OSe: C,
66.84; H, 6.73. Found: C, 66.71; H, 6.93.
1,1,2-Triphenyl-2-(2-pyridylseleno)ethanol (2f): Rf 0.34
(hexane/ethyl acetate 80/20); mp 141 °C; [R]23 +32.8 (c 0.67,
D
1
CH2Cl2); H NMR δ 5.93 (s, 1H), 5.97 (s, 1H), 6.95-7.45 (m,
16H), 7.65-7.75 (m, 2H), 8.45-8.50 (m, 1H); 13C NMR δ 58.6,
81.0, 121.1, 125.7, 126.0, 126.4, 125.4, 127.3, 127.5, 127.8,
129.9, 136.7, 139.6, 144.7, 147.8, 148.3, 152.8; IR (KBr) 3200,
1577, 1451, 1413, 1109, 1049 cm-1; MS (EI) m/z 255 (PhCHd
CPh2+). Anal. Calcd for C25H21NOSe: C, 69.76; H, 4.92; N, 3.25.
Found: C, 69.73; H, 4.70; N, 3.32. HPLC (Daicel Chiralcel OD-
H, hexane/2-propanol 80/20, 0.5 mL/min) tR 14.8 (R) and 19.5
(S) min (77% ee).
(S)-1-[1-Phenyl-1-(phenylseleno)methyl]-4-phenylcy-
clohexan-1-ol (cis- and trans-8): cis-8: Rf 0.25 (hexane/ethyl
acetate 90/10); mp 132-133 °C; [R]25D +199.1 (c 0.53, CHCl3);
1H NMR δ 1.12-2.42 (m, 8H), 2.01-2.10 (m, 2H), 4.26 (s, 1H),
7.10-7.40 (m, 15H); 13C NMR δ 29.4, 29.6, 35.4, 37.0, 43.7,
65.8, 73.2, 125.8, 126.6, 126.9, 127.3, 127.9, 128.1, 128.7, 129.5,
130.3, 133.9, 140.1, 146.6; IR (KBr) 3577, 3066, 3023, 2928,
1492, 1474, 1438, 1136, 977, 756, 737, 701, 669 cm-1; MS (FAB)
m/z 405 (M+ - OH). Anal. Calcd for C25H26OSe: C, 71.25; H,
6.22. Found: C, 70.96; H, 6.51. HPLC (Daicel Chiralpak AD-
H, hexane/iPrOH 95/5, 0.75 mL/min) tR 19.5 (R) and 25.6 (S)
Conversion of 2a to (R)-5. To a solution of the seleno
alcohol 2a (128 mg, 0.298 mmol) in nitromethane (2 mL) was
added trimethyloxonium tetrafluoroborate (88 mg, 0.596 mmol)
at room temperature and the mixture was stirred for 45 min.
Then the mixture was added to a methanol (1 mL) solution of
potassium carbonate (82 mg, 0.596 mmol). After 1 h, a
saturated aqueous NaCl solution was added and the mixture
was extracted with CH2Cl2. The combined organic extracts
were dried over Na2SO4, filtered, and concentrated under
reduced pressure to give a crude oil that was purified by
column chromatography (silica gel 10 g, hexane/ethyl acetate
95/5) affording (R)-5 (38 mg, 47%). Rf 0.39 (hexane/ethyl
min (90% ee). trans-8: Rf 0.16 (hexane/ethyl acetate 90/10);
1
[R]25 +154.3 (c 0.37, CHCl3); H NMR δ 1.45-1.90 (m, 7H),
D
2.26 (s, 1H), 2.56-2.63 (m, 2H), 4.63 (s, 1H), 7.14-7.40 (m,
15H); 13C NMR δ 30.3, 30.8, 36.3, 38.8, 42.8, 57.7, 74.4, 125.9,
126.5, 126.8, 127.5, 128.0, 128.2, 128.7, 128.9, 129.1, 134.9,
140.2, 145.6; IR (neat) 3446, 3058, 3025, 2928, 2858, 1578,
1493, 1475, 1451, 1437, 1074, 1046, 738, 698 cm-1; MS (FAB)
m/z 405 (M+ - OH). Anal. Calcd for C25H26OSe: C, 71.25; H,
6.22. Found: C, 71.05; H, 6.42.
Typical Procedure for the Preparation of Chiral
Benzylidenecyclohexanes: (M)-1-Benzylidene-4-tert-bu-
tylcyclohexane [(M)-9].28 To a solution of cis-6 (77 mg, 0.19
mmol) in CH2Cl2 (1.9 mL) was added methanesulfonyl chloride
(0.31 mL, 3.9 mmol) at 0 °C and the solution was stirred for
30 min. Triethylamine (1.3 mL, 9.3 mmol) was then added and
the reaction mixture was stirred for 1 h. The cooling bath was
removed and the mixture was stirred for an additional 1 h at
room temperature. The reaction was quenched with saturated
aqueous NH4Cl and extracted with CH2Cl2. The combined
organic extracts were washed with brine, dried over Na2SO4,
filtered, and concentrated under reduced pressure to give a
crude oil that was purified by column chromatography (silica
gel 25 g, hexane) to afford (M)-9 (39 mg, 89%). [R]25D -37.4 (c
acetate 90/10); [R]D25 -36.0 (83% ee, c 0.76, EtOH) [lit.21 [R]D
25
1
-43.2 (c 0.82, EtOH)]; H NMR δ 4.33 (s, 1H), 7.00-7.40 (m,
15H).
Conversion 2f to (S)-5. To a solution of the seleno alcohol
2f (66% ee, 60 mg, 0.139 mg) in CH2Cl2 (1 mL) was added
m-chloroperbenzoic acid (172 mg, 70% purity, 0.697 mmol) and
the solution was stirred for 5 min at room temperature. A 1
mol/L aqueous NaOH solution (3 mL) was added and the
mixture was stirred for 12 h. Workup and purification as above
gave (S)-5 (4 mg, 10%). HPLC (Daicel Chiralcel OD-H, hexane/
2-propanol 95/5, 1.0 mL/min) tR 5.1 (S) and 10.2 (R) min (58%
ee).
(S)-1-[1-Phenyl-1-(phenylseleno)methyl]-4-tert-butyl-
cyclohexan-1-ol (cis- and trans-6): cis-6: Rf 0.34 (hexane/
0.59, CH3OH) [lit. (P-isomer): [R]rt +43.3 (c 1.23, CH3OH)];
D
ethyl acetate 90/10); mp 94-95 °C; [R]25 +208.3 (c 1.62,
1H NMR δ 0.86 (s, 9H), 0.95-1.27 (m, 3H), 1.80-1.97 (m, 3H),
2.12-2.27 (m, 1H), 2.35-2.43 (m, 1H), 2.93-3.02 (m, 1H), 6.21
(s, 1H), 7.16-7.33 (m, 5H). HPLC (Daicel Chiralcel OD-H,
hexane, 0.2 mL/min) tR 27.8 (R) and 33.5 (S) min (86% ee).
D
CHCl3); 1H NMR δ 0.82 (s, 9H), 1.25-1.58 (m, 8H), 1.99-2.10
(m, 1H), 2.11 (s, 1H), 4.19 (s, 1H), 7.15-7.40 (m, 10H, Ar); 13
C
NMR δ 22.7, 22.9, 27.7, 32.4, 35.6, 37.4, 47.5, 65.7, 73.5, 126.8,
127.2, 127.7, 128.7, 129.4, 130.4, 133.8, 140.3; IR (KBr) 3449,
3056, 2956, 2865, 1578, 1479, 1435, 1364, 1262, 1245, 1074,
963, 729, 700, 688 cm-1; MS (FAB) m/z 385 (M+ - OH). Anal.
Calcd for C23H30OSe: C, 68.81; H, 7.53. Found: C, 68.59; H,
7.75. HPLC (Daicel Chiralpak AD-H, hexane/iPrOH 96/4, 0.5
mL/min) tR 15.2 (R) and 19.9 (S) min (86% ee). trans-6: Rf 0.23
(hexane/ethyl acetate 90/10); [R]25D +183.4 (c 0.97, CHCl3); 1H
NMR δ 0.75 (s, 9H), 0.96-1.52 (m, 8H), 2.01 (s, 1H), 2.45-
2.54 (m, 1H), 4.45 (s, 1H), 7.06-7.33 (m, 10H); 13C NMR δ
23.9, 24.4, 27.7, 32.4, 36.7, 39.4, 47.1, 57.1, 74.7, 126.7, 127.3,
127.9, 128.6, 129.1, 130.1, 134.8, 140.3; IR (neat) 3446, 3058,
3024, 2945, 2867, 1475, 1453, 1437, 1365, 1074, 1053, 736, 692
cm-1; MS (FAB) m/z 385 (M+ - OH). Anal. Calcd for C23H30-
OSe: C, 68.81; H, 7.53. Found: C, 68.53; H, 7.81.
(M)-1-Benzylidene-4-methylcyclohexane [(M)-10]:28 [R]25
D
-36.5 (c 0.84, CH3OH) [lit. (P-isomer): [R]rt +40.2 (c 0.33,
D
1
CH3OH)]; H NMR δ 0.92 (d, 3H, J ) 6.4 Hz), 0.88-1.19 (m,
2H), 1.54-1.70 (m, 1H), 1.73-2.00 (m, 3H), 2.15-2.40 (m, 2H),
2.82-2.90 (m, 1H), 6.22 (s, 1H), 7.16-7.29 (m, 5H). HPLC
(Daicel Chiralcel OD-H, hexane, 0.2 mL/min) tR 29.0 (R) and
40.1 (S) min (91% ee).
(M)-1-Benzylidene-4-phenylcyclohexane [(M)-11]:28 [R]25
D
-36.5 (c 0.84, CH3OH) [lit. (P-isomer): [R]rt +110.2 (c 0.67,
D
1
CH3OH)]; H NMR δ 1.49-1.76 (m, 2H), 1.94-2.12 (m, 3H),
2.31-2.53 (m, 2H), 2.68-2.83 (m, 1H), 3.00-3.07 (m, 1H), 6.30
(s, 1H), 7.17-7.32 (m, 10H). HPLC (Daicel Chiralcel OD-H,
hexane, 0.5 mL/min) tR 31.0 (R) and 41.1 (S) min (90% ee).
(S)-1-[1-Phenyl-1-(phenylseleno)methyl]-4-methylcy-
clohexan-1-ol (cis- and trans-7): cis-7: Rf 0.35 (hexane/ethyl
acetate 85/15); mp 73.5-74.5 °C; [R]25D +272.4 (c 1.65, CHCl3);
1H NMR δ 0.87 (d, 3H, J ) 5.6 Hz), 1.20-1.60 (m, 8H), 1.97-
2.05 (m, 1H), 2.08 (s, 1H), 4.19 (s, 1H), 7.12-7.38 (m, 10H);
13C NMR δ 22.3, 30.4, 30.5, 32.0, 35.2, 36.9, 65.6, 73.5, 126.8,
127.2, 127.7, 128.7, 129.4, 130.3, 133.9, 140.3; IR (KBr) 3481,
3057, 3025, 2921, 2852, 1578, 1491, 1476, 1438, 1371, 1158,
1022, 987, 737, 700, 662 cm-1; MS (FAB) m/z 343 (M+ - OH).
Anal. Calcd for C20H24OSe: C, 66.84; H, 6.73. Found: C, 66.65;
H, 6.95. HPLC (Daicel Chiralcel OD-H, hexane/iPrOH 99/1,
0.5 mL/min) tR 16.8 (R) and 24.6 (S) min (91% ee). trans-7: Rf
0.24 (hexane/ethyl acetate 85/15); [R]25D +267.0 (c 1.25, CHCl3);
Acknowledgment. This work was supported by a
Grant-in-Aid for Scientific Research (no. 11650890) from
the Ministry of Education, Science, Sports and Culture
of Japan and NIT research promotion program. We
thank Dr. Shinya Kusuda, Ono Pharmaceutical Co.,
Ltd., for the mass spectra measurements.
Supporting Information Available: Calculation results
of anti-Li-1a-TMEDA, syn-Li-1a-TMEDA, (R)-Li-1a-3a, (S)-
Li-1a-3a, (R)-Li-1b-3b, and (S)-Li-1b-3b. This material is
JO048505L
J. Org. Chem, Vol. 69, No. 25, 2004 8923